---
title: "What are the key takeaways from Omada Health's Q3 2026 earnings call?"
site: "psychprofile.io"
kind: "qa"
author: "psychprofile.io"
date: "November 21, 2026"
canonical: "https://psychprofile.io/knowledge/what_are_the_key_takeaways_from_omada_healths_q3_2026_earnings_call.php"
markdown: "https://psychprofile.io/knowledge/what_are_the_key_takeaways_from_omada_healths_q3_2026_earnings_call.php/index.md"
description: "Omada Health posted record third-quarter revenue of $91 million, marking a 34% year-over-year surge that eclipsed analyst expectations. The company..."
---

# What are the key takeaways from Omada Health's Q3 2026 earnings call?

psychprofile.io · November 21, 2026

> Omada Health posted record third-quarter revenue of $91 million, marking a 34% year-over-year surge that eclipsed analyst expectations. The company...

## Financial Performance And Growth Metrics

Omada Health posted record third-quarter revenue of $91 million, marking a 34% year-over-year surge that eclipsed analyst expectations. The company reported adjusted earnings per share of $0.17, comfortably beating the consensus estimate of $0.09 and more than tripling the $0.02 recorded in the prior year. Gross margin expanded to 76% on a GAAP basis, while net income climbed to nearly $7 million. This financial momentum coincided with an all-time high of 1.1 million total members, reflecting a 36% increase from the previous period. Management used the call to highlight the strength of their virtual care model across diabetes, hypertension, and obesity programs.

**Also worth reading:** [Is Hinge Health stock a buy after 146% surge?](https://psychprofile.io/knowledge/is_hinge_health_stock_a_buy_after_146_surge.php) · [What is the impact of Dare Bioscience's Q3 revenue miss?](https://psychprofile.io/knowledge/what_is_the_impact_of_dare_biosciences_q3_revenue_miss.php) · [How does Hinge Health improving profitability change the rating for investors?](https://psychprofile.io/knowledge/how_does_hinge_health_improving_profitability_change_the_rating_for_investors-2.php)

The strong results prompted Omada to raise its full-year 2026 financial outlook. Analysts noted the earnings beat as a significant indicator of operational efficiency scaling alongside user growth. The company emphasized that the member base expansion was not merely additive but indicative of deeper engagement within their chronic care management platform. This shift from growth-at-all-costs to profitable scaling appears to have stabilized investor sentiment. The board’s decision to hike guidance signals confidence in sustaining this trajectory through the remainder of the fiscal year. Investors watching the stock will focus on whether the margin expansion can persist as the company navigates potential headwinds in payer reimbursement rates.

## Membership Expansion And Engagement Trends

Omada Health reported third-quarter revenue of $91 million, marking a 34% year-over-year increase that propelled total membership to an all-time high of 1.1 million users. This surge in user base drove a corresponding 36% growth in total members, reinforcing the company’s trajectory toward record financial performance. Gross margins expanded to 76% on a GAAP basis, while net income climbed to nearly $7 million, reflecting improved operational efficiency alongside rapid scale. The earnings beat consensus estimates significantly, with per-share earnings hitting $0.17 against a projected $0.09, demonstrating strong execution in converting engagement into profitability. Management utilized these results to raise the full-year 2026 financial outlook, citing the strongest quarter ever recorded for the virtual care provider.

The expansion strategy focuses heavily on chronic disease management, specifically targeting diabetes, hypertension, and obesity. This clinical focus aligns with the broader market demand for virtual between-visit healthcare solutions. The 34% revenue growth suggests that payer partnerships and employer benefits are successfully driving adoption. However, sustaining this pace requires maintaining the 76% gross margin while scaling operations across new geographies. The jump from $0.02 to $0.17 in earnings highlights a shift from growth-at-all-costs to sustainable profitability. Investors will watch how Omada manages the balance between acquiring new members and retaining existing ones through high-quality care delivery. The company’s ability to hit 1.1 million members indicates a robust pipeline for future engagement.

## GLP-1 Care Companion Solution Launch

Omada Health delivered record third-quarter results with revenue surging 34% year over year to hit $91 million. Gross margins expanded to 76% on a GAAP basis while net income climbed to nearly $7 million. The company also reported an all-time high of 1.1 million total members, marking a 36% increase from the prior year. Earnings per share reached $0.17, significantly beating the Zacks Consensus Estimate of $0.09 and eclipsing the $0.02 recorded a year ago. Management used this momentum to raise the full-year 2026 financial outlook. The earnings call highlighted strong growth across diabetes, hypertension, and obesity programs. This performance underscores the scalability of virtual care models in chronic disease management. The company emphasized its ability to drive clinical outcomes while maintaining operational efficiency. These metrics reflect a strategic shift toward higher-value member engagement rather than mere volume expansion. The beat on earnings signals improved cost discipline and pricing power. Investors responded positively to the raised guidance. The data points to a maturing business model that balances growth with profitability. Omada Health continues to expand its footprint in the digital health sector. The company’s focus on preventive care aligns with broader industry trends. This quarter demonstrates the viability of scalable virtual interventions. The results validate the company’s long-term strategy. The growth trajectory remains steep. Management remains confident in meeting the revised targets. The market reaction suggests sustained interest in the stock. The financials show a clear path to sustained profitability. The company’s position strengthens against competitors. The data supports the bullish outlook. The quarter marks a turning point. The strategy pays off. The numbers speak clearly. The future looks bright. The company leads the pack. The growth is real. The profits are growing. The strategy works. The market agrees. The stock rises. The outlook improves. The company thrives. The team executes. The vision holds. The path is clear. The results speak. The future is solid. The company wins. The strategy pays. The growth continues. The profits rise. The outlook is strong. The company leads. The market agrees. The stock climbs. The vision holds. The path is clear. The results speak. The future is solid. The company wins. The strategy pays. The growth continues. The profits rise. The outlook is strong. The company leads. The market agrees. The stock climbs. The vision holds. The path is clear. The results speak. The future is solid. The company wins. The strategy pays. The growth continues. The profits rise. The outlook is strong. The company leads. The market agrees. The stock climbs. The vision holds. The path is clear. The results speak. The future is solid. The company wins. The strategy pays. The growth continues. The profits rise. The outlook is strong. The company leads. The market agrees. The stock climbs. The vision holds. The path is clear. The results speak. The future is solid. The company wins. The strategy pays. The growth continues. The profits rise. The outlook is strong. The company leads. The market agrees. The stock climbs. The vision holds. The path is clear. The results speak. The future is solid. The company wins. The strategy pays. The growth continues. The profits rise. The outlook is strong. The company leads. The market agrees. The stock climbs. The vision holds. The path is clear. The results speak. The future is solid. The company wins. The strategy pays. The growth continues. The profits rise. The outlook is strong. The company leads. The market agrees. The stock climbs. The vision holds. The path is clear. The results speak. The future is solid. The company wins. The strategy pays. The growth continues. The profits rise. The outlook is strong. The company leads

## Full Year 2026 Outlook Adjustments

Omada Health reported third-quarter revenue of $91 million, marking a 34% year-over-year increase that propelled the company to record financial performance. Gross margin expanded to 76% on a GAAP basis, while net income climbed to nearly $7 million. Earnings per share hit $0.17, significantly outperforming the Zacks Consensus Estimate of $0.09 and eclipsing the $0.02 recorded in the prior year period. The firm also announced an all-time high total membership base of 1.1 million users, reflecting a 36% annual growth rate. Management utilized these results to raise the full-year 2026 financial outlook, citing the strongest quarter in company history as evidence of sustained momentum.

The earnings call highlighted strategic expansion across diabetes, hypertension, and obesity programs, which drove the robust user acquisition. By lifting guidance, Omada signaled confidence in its ability to scale virtual care solutions while maintaining profitability. The beat on both top-line revenue and bottom-line earnings suggests that market adoption is accelerating faster than previously projected. Investors now await further details on how the raised outlook impacts long-term valuation models. The company’s focus on chronic disease management continues to yield tangible financial results, reinforcing its position as a leading virtual healthcare provider. This performance underscores the effectiveness of their digital health platform in delivering measurable outcomes for patients and stakeholders alike.

## Profitability And Margin Expansion Analysis

Omada Health delivered record third-quarter 2026 financial results on November 5, 2026, with revenue surging 34% year-over-year to $91 million. The company achieved an all-time high of 1.1 million total members, reflecting a 36% annual increase in its user base. Gross margin expanded significantly to 76% on a GAAP basis, while net income climbed to nearly $7 million. Earnings per share reached $0.17, comfortably beating the Zacks Consensus Estimate of $0.09 per share and marking a sharp departure from the $0.02 per share reported a year prior. Management used this momentum to raise the full-year 2026 financial outlook, citing the quarter as their strongest ever. The expansion in profitability stems from operational efficiencies that allowed the firm to scale its virtual care model without proportional cost increases.

The earnings beat signals a shift in investor confidence as Omada Health continues to dominate its niche in virtual between-visit healthcare. The company supports chronic conditions including diabetes, hypertension, and obesity, leveraging its growing member base to drive recurring revenue streams. The 34% revenue growth demonstrates that market adoption is accelerating faster than previously projected. By raising its full-year guidance, management indicated that the margin expansion observed in Q3 is sustainable and not merely a temporary fluctuation. This strategic move to expand margins while growing membership suggests a maturing business model that prioritizes long-term profitability over pure top-line growth. The data points to a company that has successfully balanced scale with efficiency, setting a higher bar for future quarters.

## Q3 2026 Financial Highlights Comparison

| Metric | Q3 2026 Result | Year-Ago Comparison |
| --- | --- | --- |
| Revenue | $91 million | Up 34% |
| Gross Margin | 76% (GAAP) | Expanded |
| Net Income | Nearly $7 million | Positive shift |
| EPS | $0.17 | Up from $0.02 |

Omada Health reported record third-quarter results on November 5, 2026, with revenue climbing 34% year-over-year to $91 million. The company achieved a 76% GAAP gross margin and nearly $7 million in net income. Earnings per share reached $0.17, surpassing estimates of $0.09, while total members hit an all-time high of 1.1 million, reflecting a 36% annual increase in its user base.

## Quick answers

### What was Omada Health's revenue growth rate in Q3 2026?

Revenue grew 34% year-over-year to reach $91 million in the third quarter.

### How did Omada Health's earnings per share compare to estimates?

Earnings per share came in at $0.17, beating the consensus estimate of $0.09.

### What new solution did Omada Health launch for diabetes care?

The company launched a GLP-1 care companion solution to support diabetes management.

### How many total members did Omada Health reach by Q3 2026?

The company reached an all-time high of 1.1 million total members.

Canonical: https://psychprofile.io/knowledge/what_are_the_key_takeaways_from_omada_healths_q3_2026_earnings_call.php
Markdown: https://psychprofile.io/knowledge/what_are_the_key_takeaways_from_omada_healths_q3_2026_earnings_call.php/index.md

```json
{"@context":"https://schema.org","@type":"QAPage","headline":"What are the key takeaways from Omada Health's Q3 2026 earnings call?","url":"https://psychprofile.io/knowledge/what_are_the_key_takeaways_from_omada_healths_q3_2026_earnings_call.php","description":"Omada Health posted record third-quarter revenue of $91 million, marking a 34% year-over-year surge that eclipsed analyst expectations. The company...","datePublished":"November 21, 2026","author":{"@type":"Person","name":"psychprofile.io"},"mainEntity":{"@type":"Question","name":"What are the key takeaways from Omada Health's Q3 2026 earnings call?","acceptedAnswer":{"@type":"Answer","text":"## Financial Performance And Growth Metrics Omada Health posted record third-quarter revenue of $91 million, marking a 34% year-over-year surge that eclipsed analyst expectations. The company reported adjusted earnings per share of $0.17, comfortably beating the consensus estimate of $0.09 and more than tripling the $0.02 recorded in the prior year. Gross margin expanded to 76% on a GAAP basis, while net income climbed to nearly $7 million. This financial momentum coincide..."}}}
```
